Delivery Order SPE2DB22D2211-SPE2DB25FSFPT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,401.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen (injectable migraine treatment) with a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,805.48 to supply Emgality 120 mg/ml pen/ml, a migraine treatment medication. Awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.85 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen/ml, a pharmaceutical product used in migraine treatment. This firm fixed price delivery order, issued on September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pens on June 13, 2025. This contract, issued on a firm fixed-price basis with an ultimate completion date of June 16, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical supplies to...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Emgality 120 mg/ml pens, a migraine treatment medication. This competitively awarded, non-set-aside contract has a ceiling value of $1,037.40 with a firm fixed price structure and an ultimate completion date of September 11, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Emgality 120 mg/ml pen prefilled syringes, with a ceiling value of $1,424.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $32,590.35 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen medication. This firm fixed-price delivery order, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.00 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of June 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,065.51 to AmerisourceBergen Drug Corp for Emgality 250 mg/2 mL pen (2 mL) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFPTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,187.00 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen/ml, a migraine treatment medication. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025, and was awarded on September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor under the DLA Troop Support Medical contract, AmerisourceBergen supplies pharmaceutical products to customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent success in competitive federal procurements, demonstrated through numerous delivery orders with varying values, underscores its capability to meet federal medical supply requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/23/25 |